The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, has solicited the help of worldwide companions to ascertain vaccine manufacturing amenities in Nigeria.
She mentioned that opening vaccine manufacturing firms will hasten the push by the company to achieve World Health Organisation (WHO) Maturity Level 4 for vaccine lot launch.
Adeyeye made the decision on the eighth Nigeria Pharma Manufacturers’ Expo in Lagos, collectively organised by the Pharmaceutical Manufacturing Group of Manufacturers Association of Nigeria (PMG-MAN) and PGE Expo Pvt Ltd.
A press release signed by NAFDAC’s Resident Media Consultant Sanyo Akintola mentioned the DG acknowledged the continued help of worldwide companions in NAFDAC’s attainment of Maturity Level 3, and challenged them to contribute to fill-and-finish modular vaccine manufacturing.
According to Adeyeye, NAFDAC has 9 features to satisfy for full benchmarking for medicines and vaccines, however has solely been benchmarked in eight, with lot launch for vaccines excellent.
“We want to call on our international partners that have been of tremendous help. Without them we wouldn’t have been here. I want to challenge them to contribute to fill and finish modular vaccine manufacturing so that we can get our vaccine lot release,” she mentioned.
She mentioned Nigeria has what it takes to achieve the extent besides native vaccine manufacturing, including that the associated fee has been estimated and won’t be too excessive. “We cannot afford to go back to where we used to be,” she mentioned.
Recalling that Nigeria used to fabricate vaccines, Adeyeye mentioned it’s time to return to native manufacturing.
She recommended President Bola Tinubu for the Executive Order 2024, describing it as game-changing and bringing life to NAFDAC’s clamour for incentives for native producers working underneath harsh situations.
“I was championing incentives for the manufacturers until President Tinubu came on board with the Executive Order of 2024,” she mentioned, noting that each the Coordinating Minister of Health and Minister of State purchased into the rationale resulting in unlocking the healthcare worth chain.
She mentioned NAFDAC’s Good Manufacturing Practice (GMP) Roadmap audit of over 165 firms, funded by USAID and executed by United States Pharmacopeia, led to improved high quality and 70 % lower in import of merchandise underneath the ‘5 plus 5’ and Ceiling Initiatives between 2021 and 2025.
She additionally mentioned that NAFDAC grew to become a member of International Medical Device Forum in 2023 whereas, its Yaba laboratory grew to become WHO pre-qualified in September 2023, and it grew to become first company in Sub-Saharan Africa to be efficiently re-benchmarked for Maturity Level 3.
In his remarks, Chairman of PMG-MAN, Mr. Oluwatosin Jolayemi, described the expo as solely full pharma manufacturing platform in Central and West Africa and recommended Adeyeye for driving worldwide finest practices.
He known as for extension of the presidential govt order by two years at expiration in March 2027, saying medication safety requires coverage consistency.
No fewer than 132 firms from US, China, Argentina, Egypt, India, Rwanda, Austria, UAE, France, Germany, Indonesia and Nigeria participated within the two-day expo.
Onyebuchi Ezigbo
Follow us on:
